• An, J., Liao, X., Xiao, T., Qian, S., Yuan, J., Ye, H., Qi, F., Shen, C., Wang, L., Liu, Y., Cheng, X., Li, N., Cai, Q., Wang, F.,, Chen, J., Li, G., Cai, Q., Liu, Y., Wang, Y., Zhang, F., Fu, Y., He, Q., Tan, X., Liu, L., Zhang, Z., 2020. Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test. Ann. Transl. Med. 8, 1084.

  • Cai, Q., Huang, D., Yu, H., Zhu, Z., Xia, Z., Su, Y., Li, Z., Zhou, G., Gou, J., Qu, J., Sun, Y., Liu, Y., He, Q., Chen, J.,, Liu, L., Xu, L., 2020. COVID-19: abnormal liver function tests. J. Hepatol. 73, 566-574.

  • CDC COVID-19 Response Team, 2021. SARS-CoV-2 B.1.1.529 (omicron) variant -United States, december 1-8, 2021. MMWR Morb. Mortal. Wkly. Rep. 70, 1731-1734.

  • Chang, T.H., Wu, J.L., Chang, L.Y., 2020. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J. Formos.Med. Assoc. 119, 982-989.

  • Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., Zhang, X., Zhang, M., Wu, S., Song, J., Chen, T., Han, M., Li, S., Luo, X., Zhao, J., Ning, Q., 2020a. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620-2629.

  • Chen, J., Zhang, Z.Z., Chen, Y.K., Long, Q.X., Tian, W.G., Deng, H.J., Hu, J.L., Zhang, X.X., Pu, L., Xiang, J.L., Wang, D.X., Hu, P., Zhou, F.C., Li, Z.J., Xu, H.M., Cai, X.F., Wang, D.Q., Hu, Y., Tang, N., Liu, B.Z., Wu, G.C., Huang, A.L., 2020b. The clinical and immunological features of pediatric COVID-19 patients in China. Genes Dis 7, 535-541.

  • Cloete, J., Kruger, A., Masha, M., du Plessis, N.M., Mawela, D., Tshukudu, M., Manyane, T., Komane, L., Venter, M., Jassat, W., Goga, A., Feucht, U., 2021. Rapid Rise in Paediatric COVID-19 Hospitalisations during the Early Stages of the Omicron Wave, Tshwane District, South Africa. https://doi.org/10.1101/ 2021.12.21.21268108 medRxiv.

  • Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., Tong, S., 2020. Epidemiology of COVID-19 among children in China. Pediatrics 145, e20200702.

  • García, L.F., 2020. Immune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol. 11, 1441.

  • Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D.S.C., Du, B., Li, L.J., Zeng, G., Yuen, K.Y., Chen, R.C., Tang, C.L., Wang, T., Chen, P.Y., Xiang, J., Li, S.Y., Wang, J.L., Liang, Z.J., Peng, Y.X., Wei, L., Liu, Y., Hu, Y.H., Peng, P., Wang, J.M., Liu, J.Y., Chen, Z., Li, G., Zheng, Z.J., Qiu, S.Q., Luo, J., Ye, C.J., Zhu, S.Y., Zhong, N.S., 2020. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708-1720.

  • Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J., Cao, B., 2020. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet 395, 497-506.

  • Jamal, Z., Haider, M., Ikram, A., Salman, M., Rana, M.S., Rehman, Z., Haider, S.A., Ammar, M., Nisar, N., Umair, M., 2022. Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan. Front. Public Health 10, 987452.

  • Kannan, S., Shaik Syed Ali, P., Sheeza, A., 2021. Omicron (b.1.1.529) - variant of concern- molecular profile and epidemiology: a mini review. Eur. Rev. Med. Pharmacol. Sci. 25, 8019-8022.

  • Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., Xu, H., 2020. Positive RT-PCR test results in patients recovered from COVID-19. JAMA 323, 1502-1503.

  • Lee, J., Park, S., Kim, J.Y., Lim, S.Y., Chang, E., Bae, S., Jung, J., Kim, M.J., Chong, Y.P., Lee, S.O., Choi, S.H., Kim, Y.S., Lee, N., Shum, D., Kim, S., Jee, Y., Kim, S.H., 2022. No correlation of neutralizing antibody titers against the omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough omicron infections among healthcare workers. J. Infect. S0163-4453(22)00600-4.

  • Li, Q., Shuai, L., Tan, L., Song, L., Ou, C., Song, X., He, J., Gao, M., Hu, X., Liu, Y., Chen, H., Zou, Z., Yu, C., Qin, B., Xu, W., 2021. Clinical characteristics and prediction analysis of the recovered COVID-19 patients with re-detectable positive rna test. Am J Transl Res 13, 14157-14167.

  • Ling, Y., Xu, S.B., Lin, Y.X., Tian, D., Zhu, Z.Q., Dai, F.H., Wu, F., Song, Z.G., Huang, W., Chen, J., Hu, B.J., Wang, S., Mao, E.Q., Zhu, L., Zhang, W.H., Lu, H.Z., 2020.

  • Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin. Med. J. 133, 1039-1043.

  • Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., Chen, J., Meng, Y., Wang, J., Lin, Y., Yuan, J., Xie, Z., Ma, J., Liu, W.J., Wang, D., Xu, W., Holmes, E.C., Gao, G.F., Wu, G., Chen, W., Shi, W., Tan, W., 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565-574.

  • Nardo, A.D., Schneeweiss-Gleixner, M., Bakail, M., Dixon, E.D., Lax, S.F., Trauner, M., 2021. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 41, 20-32.

  • Nikolopoulou, G.B., Maltezou, H.C., 2022. COVID-19 in children: where do we stand? Arch. Med. Res. 53, 1-8.

  • Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., Tian, D.S., 2020. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China. Clin. Infect. Dis. 71, 762-768.

  • Qiu, H., Wu, J., Hong, L., Luo, Y., Song, Q., Chen, D., 2020. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID -19) in zhejiang, China: an observational cohort study. Lancet Infect. Dis. 20, 689-696.

  • Qu, Y.M., Kang, E.M., Cong, H.Y., 2020. Positive result of SARS-CoV-2 in sputum from a cured patient with COVID-19. Trav. Med. Infect. Dis. 34, 101619.

  • Schmidt, F., Weisblum, Y., Rutkowska, M., Poston, D., DaSilva, J., Zhang, F., Bednarski, E., Cho, A., Schaefer-Babajew, D.J., Gaebler, C., Caskey, M., Nussenzweig, M.C., Hatziioannou, T., Bieniasz, P.,D., 2021. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature 600, 512-516.

  • Skok, K., Stelzl, E., Trauner, M., Kessler, H.H., Lax, S.F., 2021. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage.

  • Virchows Arch. 478, 343-353.

  • Štefan, M., Dlouhý, P., Bezdíčková, L., 2021. Vaccination against COVID-19. Klinická Mikrobiol. a Infekcní Lékarství 27, 49-60 (In Czech).

  • Tezer, H., Bedir Demirdağ, T., 2020. Novel coronavirus disease (COVID-19) in children. Turk. J. Med. Sci. 50, 592-603.

  • Tian, D., Sun, Y., Xu, H., Ye, Q., 2022. The emergence and epidemic characteristics of the highly mutated sars-cov-2 omicron variant. J. Med. Virol. 94, 2376-2383.

  • World Health Organization, 2020. Laboratory Testing Strategy Recommendations for COVID-19: Interim Guidance. https://www.who.int/publications/i/item/laboratory-testing-strategy-recommendations-for-covid-19-interim-guidance. (Accessed 21 March 2020).

  • World Health Organization, 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. https://www.who.intnewsitem/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. (Accessed 26 November 2021).

  • Wu, H., Zhu, H., Yuan, C., Yao, C., Luo, W., Shen, X., Wang, J., Shao, J., Xiang, Y., 2020. Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in wuhan, China. JAMA Netw. Open 3, e2010895.

  • Xu, L., Liu, J., Lu, M., Yang, D., Zheng, X., 2020. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 40, 998-1004.

  • Zhang, C., Shi, L., Wang, F.S., 2020. Liver injury in COVID -19: management and challenges. Lancet Gastroenterol Hepatol 5, 428-430.

  • Zhang, X., Wu, S., Wu, B., Yang, Q., Chen, A., Li, Y., Zhang, Y., Pan, T., Zhang, H., He, X., 2021. SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct. Targeted Ther. 6, 430.

  • Zhang, Y., Han, S., Yao, M., Guo, X., Zhao, L., Sun, W., Wang, S., Pang, B., Zhang, S., Wang, J., Fang, M., Liu, X., Kou, Z., Jiang, X., 2022. Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron variant. J. Infect. S0163-4453(22) 00620-X.

  • Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., Chen, H.D., Chen, J., Luo, Y., Guo, H., Jiang, R.D., Liu, M.Q., Chen, Y., Shen, X.R., Wang, X., Zheng, X.S., Zhao, K., Chen, Q.J., Deng, F., Liu, L.L., Yan, B., Zhan, F.X., Wang, Y.Y., Xiao, G.F., Shi, Z.L., 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-273.